We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.89%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$74.4B
AUM Growth
+$7.26B
(+11%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
3.31%
Top 10 Holdings %
Top 10 Hldgs %
19.47%
Holding
3,107
New
25
Increased
2,535
Reduced
421
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$141M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$96.6M |
| 4 |
Amazon
AMZN
|
+$63.7M |
| 5 |
Prologis
PLD
|
+$47.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$56.3M |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$36M |
| 3 |
Y
Alleghany Corp
Y
|
+$33M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$26.6M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$20.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.05% |
| 2 | Healthcare | 14.94% |
| 3 | Financials | 14.18% |
| 4 | Consumer Discretionary | 10% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Nature's Sunshine
NATR
$288M
| $169K | ﹤0.01% |
20,288
+34
| +0.2% | +$288 |
|
|
VCSA
2827
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $169K | ﹤0.01% |
6,714
+238
| +4% | +$11.1K |
|
|
HYZN
2828
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $168K | ﹤0.01% |
2,169
+45
| +2% | +$3.84K |
|
2829
Absci
ABSI
$1.51B
| $167K | ﹤0.01% |
79,342
+61
| +0.1% | +$167 |
|
|
OMIC
2830
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $167K | ﹤0.01% |
2,762
+10
| +0.4% | +$670 |
|
|
LONA
2831
LeonaBio Inc
LONA
$72.1M
| $166K | ﹤0.01% |
5,225
+179
| +4% | +$5.64K |
|
2832
Atomera
ATOM
$214M
| $166K | ﹤0.01% |
26,621
+776
| +3% | +$6.36K |
|
|
SBT
2833
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $166K | ﹤0.01% |
27,279
-995
| -4% | -$6.24K |
|
2834
Foghorn Therapeutics
FHTX
$360M
| $164K | ﹤0.01% |
25,751
+973
| +4% | +$7.34K |
|
|
PVBC
2835
DELISTED
Provident Bancorp
PVBC
| $164K | ﹤0.01% |
22,486
+84
| +0.4% | +$852 |
|
2836
Lifetime Brands
LCUT
$211M
| $163K | ﹤0.01% |
21,465
+264
| +1% | +$2.04K |
|
|
VIEW
2837
DELISTED
View, Inc. Class A Common Stock
VIEW
| $162K | ﹤0.01% |
2,793
+70
| +3% | +$5.12K |
|
2838
Ivanhoe Electric
IE
$1.74B
| $161K | ﹤0.01% |
13,214
+2,189
| +20% | +$22.9K |
|
|
RSVR
2839
Reservoir Media
RSVR
$667M
| $159K | ﹤0.01% |
26,550
-135
| -0.5% | -$771 |
|
2840
Century Therapeutics
IPSC
$361M
| $158K | ﹤0.01% |
30,739
+222
| +0.7% | +$2.1K |
|
2841
Tyra Biosciences
TYRA
$1.58B
| $158K | ﹤0.01% |
20,748
+115
| +0.6% | +$813 |
|
2842
Outlook Therapeutics
OTLK
$191M
| $157K | ﹤0.01% |
7,275
-9
| -0.1% | -$196 |
|
2843
FTC Solar
FTCI
$44.9M
| $155K | ﹤0.01% |
5,781
+264
| +5% | +$6.25K |
|
2844
Nerdy
NRDY
$96.7M
| $155K | ﹤0.01% |
68,821
+1,423
| +2% | +$3.09K |
|
|
PFSW
2845
DELISTED
PFSweb, Inc.
PFSW
| $155K | ﹤0.01% |
25,211
+358
| +1% | +$3.34K |
|
2846
Skillsoft
SKIL
$81.6M
| $154K | ﹤0.01% |
5,923
+30
| +0.5% | +$1K |
|
|
TBCH
2847
Turtle Beach Corp
TBCH
$277M
| $153K | ﹤0.01% |
21,387
+831
| +4% | +$6.51K |
|
2848
Arena Group
AREN
$83.8M
| $151K | ﹤0.01% |
14,229
-95
| -0.7% | -$1.23K |
|
2849
TechnipFMC
FTI
$27.3B
| $150K | ﹤0.01% |
+12,317
| New | +$138K |
|
2850
Crawford & Co Class A
CRD.A
$669M
| $148K | ﹤0.01% |
26,621
-219
| -0.8% | -$1.33K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2022 Portfolio in Review
As of Q4 2022, RhumbLine Advisers held 3,107 positions worth $74.4B, up 11% from $67.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
RhumbLine Advisers deployed $2.46B of net new capital in Q4 2022, opening 25 new positions and adding to 2,535 existing holdings. Its largest new stake was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Steel Dynamics, an estimated $18.8M trimmed.
- RhumbLine Advisers's largest Q4 2022 buy was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
- RhumbLine Advisers added most to Microsoft in Q4 2022, an estimated $141M increase.
- RhumbLine Advisers's biggest Q4 2022 reduction was Steel Dynamics, cutting an estimated $18.8M.
- RhumbLine Advisers fully exited Twitter, Inc. in Q4 2022, selling an estimated $56.3M.
- RhumbLine Advisers's ten largest holdings make up 19% of its $74.4B portfolio in Q4 2022.
- RhumbLine Advisers opened 25 new positions and closed 97 in Q4 2022.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $74.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.